|
nasdaq:biib
|
3961
|
Apr 21st, 2024 12:00AM
|
Biogen
|
972K
|
8092
|
Open
|
|
Apr 20th, 2024 11:01PM
|
Apr 20th, 2024 11:01PM
|
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
|
Open
|
|
Open
|
225 Binney Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Biogen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:biib
|
3961
|
Apr 20th, 2024 12:00AM
|
Biogen
|
971K
|
8096
|
Open
|
|
Apr 19th, 2024 11:00PM
|
Apr 20th, 2024 04:39PM
|
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
|
Open
|
|
Open
|
225 Binney Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Biogen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:biib
|
3961
|
Apr 19th, 2024 12:00AM
|
Biogen
|
971K
|
8105
|
Open
|
|
Apr 18th, 2024 11:09PM
|
Apr 18th, 2024 11:09PM
|
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
|
Open
|
|
Open
|
225 Binney Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Biogen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:biib
|
3961
|
Apr 18th, 2024 12:00AM
|
Biogen
|
971K
|
8105
|
Open
|
|
Apr 17th, 2024 11:06PM
|
Apr 18th, 2024 05:58PM
|
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
|
Open
|
|
Open
|
225 Binney Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Biogen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:biib
|
3961
|
Apr 17th, 2024 12:00AM
|
Biogen
|
970K
|
8106
|
Open
|
|
Apr 16th, 2024 10:54PM
|
Apr 17th, 2024 02:22PM
|
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
|
Open
|
|
Open
|
225 Binney Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Biogen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:biib
|
3961
|
Apr 16th, 2024 12:00AM
|
Biogen
|
970K
|
8107
|
Open
|
|
Apr 15th, 2024 10:48PM
|
Apr 16th, 2024 10:39AM
|
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
|
Open
|
|
Open
|
225 Binney Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Biogen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:biib
|
3961
|
Apr 15th, 2024 12:00AM
|
Biogen
|
970K
|
8109
|
Open
|
|
Apr 14th, 2024 10:49PM
|
Apr 15th, 2024 04:20PM
|
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
|
Open
|
|
Open
|
225 Binney Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Biogen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:biib
|
3961
|
Apr 14th, 2024 12:00AM
|
Biogen
|
969K
|
8114
|
Open
|
|
Apr 13th, 2024 10:41PM
|
Apr 14th, 2024 10:39AM
|
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
|
Open
|
|
Open
|
225 Binney Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Biogen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:biib
|
3961
|
Apr 13th, 2024 12:00AM
|
Biogen
|
969K
|
8114
|
Open
|
|
Apr 12th, 2024 10:31PM
|
Apr 13th, 2024 11:07AM
|
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
|
Open
|
|
Open
|
225 Binney Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Biogen
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:biib
|
3961
|
Apr 12th, 2024 12:00AM
|
Biogen
|
969K
|
8117
|
Open
|
|
Apr 11th, 2024 10:35PM
|
Apr 12th, 2024 08:02AM
|
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
|
Open
|
|
Open
|
225 Binney Street
|
Cambridge
|
MA
|
US
|
02142
|
|
Biogen
|
Health Care
|
Pharmaceuticals & Biotechnology
|